Abstract

Myxomatous mitral valve disease (MMVD) causing mitral regurgitation is the most important disease of the heart in small animal cardiovascular medicine. Because MMVD is an example of a chronic disease that progresses from mild to severe over years, treatment strategies change with the stage of the disease. In this review the treatment options are compared and contrasted as they are discussed relative to the recently published ACVIM consensus statement regarding the treatment of MMVD. Results from clinical trials and evidence-based medicine are likely to provide significant improvements in the management of MMVD in the coming decades. (C) 2012 Elsevier B.V. All rights reserved.

Keywords

Canine; Myxomatous mitral valve disease; Treatment heart disease

Published in

Journal of Veterinary Cardiology
2012, Volume: 14, number: 1, pages: 165-184
Publisher: ELSEVIER SCIENCE BV

SLU Authors

• Häggström, Jens

  • Department of Clinical Sciences, Swedish University of Agricultural Sciences
    

UKÄ Subject classification

Clinical Science


Publication identifier

DOI: https://doi.org/10.1016/j.jvc.2012.02.002

Permanent link to this page (URI)

https://res.slu.se/id/publ/60216